Abstract
A double-blind comparative trial showed that intermittent levamisole therapy (150 mg daily for 3 days of each week) was as effective as continuous therapy (150 mg daily) in rheumatoid arthritis and with slightly fewer side effects.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boardman P. L., Hart F. D. Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis. Br Med J. 1967 Nov 4;4(5574):264–268. doi: 10.1136/bmj.4.5574.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huskisson E. C., Scott J., Balme H. W., Dieppe P. A., Trapnell J., Willoughby D. A. Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet. 1976 Feb 21;1(7956):393–395. doi: 10.1016/s0140-6736(76)90218-x. [DOI] [PubMed] [Google Scholar]
- Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
- Rosenthal M., Trabert U., Müller W. Immunotherapy with levamisole in rheumatic diseases. Scand J Rheumatol. 1976;5(4):216–220. doi: 10.3109/03009747609099908. [DOI] [PubMed] [Google Scholar]
- Veys E. M., Mielants H., de Bussere A., Decrans L., Gabriel P. Letter: Levamisole in rheumatoid arthritis. Lancet. 1976 Apr 10;1(7963):808–809. doi: 10.1016/s0140-6736(76)91651-2. [DOI] [PubMed] [Google Scholar]